title: Is there a place for G-CSF in viral hepatitis-induced agranulocytosis?
authors.forename: E
authors.initials: E
authors.lastname: Valsesia
authors.forename: J
authors.initials: J
authors.lastname: Gardais
authors.forename: P
authors.initials: P
authors.lastname: Calès
authors.forename: S
authors.initials: S
authors.lastname: Carpentier
authors.forename: C
authors.initials: C
authors.lastname: Foussard
authors.forename: P
authors.initials: P
authors.lastname: Burtin
authors.forename: N
authors.initials: N
authors.lastname: Ifrah
authors.forename: J
authors.initials: J
authors.lastname: Boyer
mesh_terms: D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000209:etiology* / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D008297:Male
chemical_list: D016179:Granulocyte Colony-Stimulating Factor